Canada Tissue Diagnostics Market Size & Outlook, 2025-2030
Related Markets
Canada tissue diagnostics market highlights
- The Canada tissue diagnostics market generated a revenue of USD 268.5 million in 2024 and is expected to reach USD 383.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 6.3% from 2025 to 2030.
- In terms of segment, immunohistochemistry was the largest revenue generating technology in 2024.
- Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.
Tissue diagnostics market data book summary
| Market revenue in 2024 | USD 268.5 million |
| Market revenue in 2030 | USD 383.7 million |
| Growth rate | 6.3% (CAGR from 2025 to 2030) |
| Largest segment | Immunohistochemistry |
| Fastest growing segment | Digital Pathology and Workflow |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
Other key industry trends
- In terms of revenue, Canada accounted for 3.1% of the global tissue diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. tissue diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 494.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tissue Diagnostics Market Scope
Tissue Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DiaGenic | View profile | 11-50 | Oslo, Oslo, Norway, Europe | http://www.diagenic.com/ |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | https://www.cellsignal.com |
| Bio SB | View profile | 11-50 | Goleta, California, United States, North America | https://www.biosb.com/ |
| Biogenex | View profile | 51-100 | Fremont, California, United States, North America | https://biogenex.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE Aerospace | View profile | 125000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | https://www.geaerospace.com |
| Siemens AG | View profile | 321000 | Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 | https://www.siemens.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Canada tissue diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 27.26% in 2024. Horizon Databook has segmented the Canada tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
Breast cancer is a leading cancer type in Canada. Canada is the second largest market in North America tissue diagnostics. Canadian Breast Cancer Foundation is continually working for creating awareness about cancer, which creates growth opportunities for tissue diagnostics.
According to Canadian Cancer Society, approximately half of the Canadian population is expected to be diagnosed with cancer in their lifetime. As per 2017 annual report of Canadian Cancer Statistics, the number of cancer patients increased due to rise in geriatric population.
However, it was observed that survival rate has increased over the past few years due to cancer prevention programs, early detection methods, and better treatment options. Canadian Partnership Against Cancer maintains the Screening and Early Detection portfolio with partnerships across Canada.
Reasons to subscribe to Canada tissue diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada tissue diagnostics market databook
-
Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada tissue diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada tissue diagnostics market size, by technology, 2018-2030 (US$M)
Canada Tissue Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
